James William Dodd
Impact in
-
- Intensive Care Unit Cognitive Disorders
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 27
- Respiratory Support and Mechanisms 11
- Infection Control and Ventilation 3
- Neonatal Respiratory Health Research 3
- Respiratory and Cough-Related Research 3
- Physiology 12
- Asthma and respiratory diseases 10
- Co-authors
- Paul Jones (12 shared papers)Spas Getov (1 shared paper)Martin D. van den Broek (2 shared papers)Rebecca A. Charlton (3 shared papers)Jason Viner (4 shared papers)David Arnold (4 shared papers)Fergus Hamilton (5 shared papers)Huzaifa I. Adamali (2 shared papers)
- Journals
- BMJ Open Respiratory Research (11 papers)European Respiratory Journal (10 papers)Thorax (9 papers)The Lancet (8 papers)The Lancet Respiratory Medicine (3 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
James William Dodd
83 papers receiving 4.6k citations
James William Dodd's Hit Papers
Peers
Comparison fields: 5 of 145
- Critical Care and Intensive Care Medicine 334
- Infectious Diseases 1.2k
- Pulmonary and Respiratory Medicine 1.8k
- Neurology 790
- Applied Microbiology and Biotechnology 50
Countries citing papers authored by James William Dodd
This map shows the geographic impact of James William Dodd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James William Dodd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James William Dodd more than expected).
Fields of papers citing papers by James William Dodd
This network shows the impact of papers produced by James William Dodd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James William Dodd. The network helps show where James William Dodd may publish in the future.
Co-authors
The 25 scholars most cited alongside James William Dodd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort Hit paper breakdown → | 2020 | 467 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 4 | 2010 | 338 | |
| 5 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 6 | BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults Hit paper breakdown → | 2016 | 253 |
| 7 | Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19 Hit paper breakdown → | 2022 | 250 |
| 8 | 2011 | 248 | |
| 9 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 10 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 11 | 2015 | 156 | |
| 12 | 2012 | 123 | |
| 13 | 2013 | 120 | |
| 14 | Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry Hit paper breakdown → | 2023 | 116 |
| 15 | 2023 | 83 | |
| 16 | 2021 | 57 | |
| 17 | 2012 | 56 | |
| 18 | 2021 | 55 | |
| 19 | 2013 | 55 | |
| 20 | 2021 | 54 |
About James William Dodd
James William Dodd is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Infectious Diseases, Public Health, Environmental and Occupational Health and Geriatrics and Gerontology, having authored 97 papers that have together received 4.8k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (27 papers), Respiratory Support and Mechanisms (11 papers), Asthma and respiratory diseases (10 papers), Non-Invasive Vital Sign Monitoring (4 papers), COVID-19 and healthcare impacts (4 papers), Infection Control and Ventilation (3 papers), Neonatal Respiratory Health Research (3 papers) and Respiratory and Cough-Related Research (3 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (334 citations), Infectious Diseases (1.2k citations), Pulmonary and Respiratory Medicine (1.8k citations), Neurology (790 citations) and Applied Microbiology and Biotechnology (50 citations). James William Dodd has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Paul Jones, Spas Getov, Martin D. van den Broek, Rebecca A. Charlton, Jason Viner, David Arnold, Fergus Hamilton, Huzaifa I. Adamali, Ed Moran and Anna J. Morley. Their work appears in journals such as BMJ Open Respiratory Research, European Respiratory Journal, Thorax, The Lancet and The Lancet Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.